Barbara S. Frazier

Array ( [id] => 2932832 [patent_doc_number] => 05196416 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-03-23 [patent_title] => 'Transdermal flux-enhancing pharmaceutical compositions comprising azone, ethanol and water' [patent_app_type] => 1 [patent_app_number] => 7/679164 [patent_app_country] => US [patent_app_date] => 1991-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3327 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 131 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/196/05196416.pdf [firstpage_image] =>[orig_patent_app_number] => 679164 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3930084 [patent_doc_number] => 05980864 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-09 [patent_title] => '1,4,7,10-tetraazacyclododecane butyltriols, processes for their production and pharmaceutical agents containing them' [patent_app_type] => 1 [patent_app_number] => 7/671041 [patent_app_country] => US [patent_app_date] => 1991-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7364 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/980/05980864.pdf [firstpage_image] =>[orig_patent_app_number] => 671041 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2975379 [patent_doc_number] => 05182299 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-01-26 [patent_title] => 'Treatment of osmotic disturbance with organic osmolytes' [patent_app_type] => 1 [patent_app_number] => 7/670779 [patent_app_country] => US [patent_app_date] => 1991-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 26 [patent_no_of_words] => 21441 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/182/05182299.pdf [firstpage_image] =>[orig_patent_app_number] => 670779 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2840087 [patent_doc_number] => 05160726 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1992-11-03 [patent_title] => 'Filter sterilization for production of colloidal, superparamagnetic MR contrast agents' [patent_app_type] => 1 [patent_app_number] => 7/650957 [patent_app_country] => US [patent_app_date] => 1991-02-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 5521 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 107 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/160/05160726.pdf [firstpage_image] =>[orig_patent_app_number] => 650957 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2790368 [patent_doc_number] => 05143716 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1992-09-01 [patent_title] => 'Phosphorylated sugar alcohols, Mono- and Di-Saccharides as contrast agents for use in magnetic resonance imaging of the gastrointestinal region' [patent_app_type] => 1 [patent_app_number] => 7/649437 [patent_app_country] => US [patent_app_date] => 1991-02-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 6845 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 82 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/143/05143716.pdf [firstpage_image] =>[orig_patent_app_number] => 649437 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2933255 [patent_doc_number] => 05196437 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-03-23 [patent_title] => 'Method for treating hepatic diseases and regenerating liver tissue using FK 506 and related compounds' [patent_app_type] => 1 [patent_app_number] => 7/629028 [patent_app_country] => US [patent_app_date] => 1990-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4393 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/196/05196437.pdf [firstpage_image] =>[orig_patent_app_number] => 629028 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2812110 [patent_doc_number] => 05122363 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1992-06-16 [patent_title] => 'Zeolite-enclosed transistion and rare earth metal ions as contrast agents for the gastrointestinal tract' [patent_app_type] => 1 [patent_app_number] => 7/624106 [patent_app_country] => US [patent_app_date] => 1990-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 2 [patent_no_of_words] => 4139 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/122/05122363.pdf [firstpage_image] =>[orig_patent_app_number] => 624106 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2923084 [patent_doc_number] => 05186923 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-02-16 [patent_title] => 'Enhancement of cellular accumulation of lipophilic cationic organometallic compounds by reduction of intramembrane potential' [patent_app_type] => 1 [patent_app_number] => 7/594813 [patent_app_country] => US [patent_app_date] => 1990-10-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 9 [patent_no_of_words] => 8880 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/186/05186923.pdf [firstpage_image] =>[orig_patent_app_number] => 594813 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2825591 [patent_doc_number] => 05128121 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1992-07-07 [patent_title] => 'Mixture of a positive and negative contrast agent for magnetic resonance imaging' [patent_app_type] => 1 [patent_app_number] => 7/585140 [patent_app_country] => US [patent_app_date] => 1990-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 9 [patent_no_of_words] => 6270 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/128/05128121.pdf [firstpage_image] =>[orig_patent_app_number] => 585140 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2788778 [patent_doc_number] => 05100898 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1992-03-31 [patent_title] => 'Antitussive liquid compositions containing dyclonine' [patent_app_type] => 1 [patent_app_number] => 7/590319 [patent_app_country] => US [patent_app_date] => 1990-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2375 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 112 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/100/05100898.pdf [firstpage_image] =>[orig_patent_app_number] => 590319 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2830465 [patent_doc_number] => 05128374 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1992-07-07 [patent_title] => 'Use of calcium citrate malate for the treatment of osteoporosis and related disorders' [patent_app_type] => 1 [patent_app_number] => 7/590314 [patent_app_country] => US [patent_app_date] => 1990-09-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3751 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/128/05128374.pdf [firstpage_image] =>[orig_patent_app_number] => 590314 [rel_patent_id] =>[rel_patent_doc_number] =>)